💡 Bottom Line
Ozempic and Wegovy are the same drug (semaglutide) by the same manufacturer (Novo Nordisk). Ozempic is approved for diabetes; Wegovy is approved for weight loss. Ozempic has better insurance coverage for diabetes but worse coverage for weight loss. Self-pay pricing is nearly identical at $349/month through NovoCare.

Ozempic and Wegovy contain the exact same active ingredient — semaglutide — made by the same company. The only differences are the FDA-approved indication, the available doses, and how insurance covers them.

Price Comparison

Pricing PathwayOzempicWegovy (Injection)Wegovy (Pill)
List price$935/mo$1,349/mo$1,349/mo
NovoCare self-pay$349/mo$349/mo$149–299/mo
NovoCare intro$199 (2 fills)$199 (2 fills)$149
Insurance for diabetesBroadly coveredNot indicatedNot indicated
Insurance for weight lossOff-label (rare)~40% of plans~40% of plans
Medicare (July 2026+)Covered for diabetes$50/mo (Bridge)$50/mo (Bridge)
List price Jan 2027$675/mo$675/mo$675/mo

The Insurance Routing Trick

Here's the key strategic insight: if you have type 2 diabetes or prediabetes (A1C of 5.7% or higher), your insurance is far more likely to cover Ozempic than Wegovy. Both contain semaglutide and will produce weight loss, but Ozempic's diabetes indication gives it broader formulary coverage.

Talk to your doctor about which formulation makes sense given your diagnoses. If you have any metabolic condition, the diabetes-approved version may be your cheapest path to semaglutide.

When Cash-Pay Makes More Sense

If insurance doesn't cover either version, compounded semaglutide is the most affordable option:

ProviderStarting PriceDetails
Get Thin MD$119/moCheck Price → Paid link
Yucca Health$149/moCheck Price → Paid link
Novi$174/moCheck Price → Paid link
Sesame Carefrom $199Check Price → Paid link

Key Takeaways

Compare All GLP-1 Prices

See today's lowest verified prices from vetted telehealth providers.

Compare Prices →
Paid link · Compounded medications are not FDA-approved.